Inventor · disambiguated record
Joseph B. Santella
Also filed as: SANTELLA III JOSEPH B · SANTELLA III JOSEPH BASIL · SANTELLA JOSEPH B · SANTELLA JOSEPH B III
48 granted patents·7 pending applications·603 citations·filing 1993–2019
98Inventor score
Files withBRISTOL MYERS SQUIBB CO24BRISTOL MYERS SQUIBB PHARMA CO14DU PONT MERCK PHARMA4SANTELLA JOSEPH B2BRISTOL MYERS SQUIBB PHARMA1
Top patents by PatentIndex Score
55 records- 0193US7183270B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 27, 2007·52 cites·19 claims
- 0293US5563127ABoronic acid and ester inhibitors of thrombinDU PONT MERCK PHARMA·Filed 1994·Granted Oct 8, 1996·74 cites·7 claims
- 0392US6331541B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 1999·Granted Dec 18, 2001·57 cites·42 claims
- 0491US7601844B2Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 13, 2009·19 cites·8 claims
- 0591US6759411B2Heterocyclic piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 6, 2004·26 cites·45 claims
- 0691US6521592B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Feb 18, 2003·28 cites·16 claims
- 0789US6605623B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Aug 12, 2003·36 cites·27 claims
- 0888US10294229B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 21, 2019·9 cites·13 claims
- 0988US5698538ABoronic acid and ester inhibitors of thrombinDU PONT MERCK PHARMA·Filed 1996·Granted Dec 16, 1997·42 cites·7 claims
- 1087US9540333B2Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNαBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 10, 2017·11 cites·16 claims
- 1184US7338947B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 4, 2008·6 cites·21 claims
- 1282US6441001B12-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Aug 27, 2002·26 cites·59 claims
- 1381US9657009B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 23, 2017·4 cites·11 claims
- 1481US9169252B2Heteroaryl substituted nicotinamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 27, 2015·5 cites·9 claims
- 1580US9546153B2Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 17, 2017·5 cites·9 claims
- 1680US7985861B2Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jul 26, 2011·3 cites·13 claims
- 1779US8633226B2Piperidinyl derivative as a modulator of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Jan 21, 2014·3 cites·8 claims
- 1879US6444686B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRSITOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Sep 3, 2002·58 cites·49 claims
- 1979US6214851B1N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agentDU PONT PHARM CO·Filed 2000·Granted Apr 10, 2001·12 cites·7 claims
- 2078US10202390B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 12, 2019·3 cites·12 claims
- 2178US8642622B2Piperidinyl compound as a modulator of chemokine receptor activityCHERNEY ROBERT J·Filed 2011·Granted Feb 4, 2014·4 cites·8 claims
- 2278US8299098B2Piperidinyl derivative as a modulator of chemokine receptor activitySANTELLA JOSEPH B·Filed 2009·Granted Oct 30, 2012·4 cites·4 claims
- 2378US6331545B1Heterocycyclic piperidines as modulators of chemokine receptor activityFiled 1999·Granted Dec 18, 2001·18 cites·53 claims
- 2475US6780857B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Aug 24, 2004·6 cites·27 claims
- 2574US6608227B1Benzylcycloalkyl amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA·Filed 2000·Granted Aug 19, 2003·7 cites·37 claims
- 2674US6586446B1Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 1, 2003·8 cites·56 claims
- 2773US6864380B2Benzylcycloalkyl amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Mar 8, 2005·5 cites·22 claims
- 2872US6784200B2Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Aug 31, 2004·4 cites·38 claims
- 2972US6492400B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Dec 10, 2002·15 cites·23 claims
- 3071US8501782B2Piperidinyl derivatives as modulators of chemokine receptor activityGARDNER DANIEL S·Filed 2008·Granted Aug 6, 2013·3 cites·11 claims
- 3168US10479793B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 19, 2019·1 cites·3 claims
- 3268US6706735B22-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 16, 2004·3 cites·35 claims
- 3368US5395844AImidazole 5-position substituted angiotensin II antagonistsDU PONT MERCK PHARMA·Filed 1993·Granted Mar 7, 1995·10 cites·5 claims
- 3467US6906066B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 14, 2005·3 cites·31 claims
- 3567US6875776B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Apr 5, 2005·3 cites·22 claims
- 3666US6960666B2Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Nov 1, 2005·2 cites·56 claims
- 3766US6486180B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Nov 26, 2002·10 cites·32 claims
- 3863US7291744B2N-ureidoalkyl-amino compounds as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 6, 2007·2 cites·22 claims
- 3963US5545651AImidazole 5-position substituted angiotensin II antagonistsDU PONT MERCK PHARMA·Filed 1994·Granted Aug 13, 1996·16 cites·5 claims
- 4061US2008114052A1Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 4159US7550500B2Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 23, 2009·0 cites·27 claims
- 4258US10544133B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·0 cites·9 claims
- 4355US6992091B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 31, 2006·0 cites·7 claims
- 4454US10023562B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 17, 2018·0 cites·11 claims
- 4553US7312222B2Heterocyclic piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Dec 25, 2007·0 cites·43 claims
- 4653US2005192291A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 2004·Application pending·0 cites
- 4751US2005096325A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 2004·Application pending·0 cites
- 4851US2006069128A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityDUNCIA JOHN V·Filed 2005·Application pending·0 cites
- 4950US2011245226A1Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 5049US2013178444A1Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph B. Santella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →